rs3735713
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_024915.4(GRHL2):c.*41G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.364 in 1,158,186 control chromosomes in the GnomAD database, including 80,620 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.38 ( 11171 hom., cov: 31)
Exomes 𝑓: 0.36 ( 69449 hom. )
Consequence
GRHL2
NM_024915.4 3_prime_UTR
NM_024915.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.369
Genes affected
GRHL2 (HGNC:2799): (grainyhead like transcription factor 2) The protein encoded by this gene is a transcription factor that can act as a homodimer or as a heterodimer with either GRHL1 or GRHL3. Defects in this gene are a cause of non-syndromic sensorineural deafness autosomal dominant type 28 (DFNA28).[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 8-101666744-G-A is Benign according to our data. Variant chr8-101666744-G-A is described in ClinVar as [Benign]. Clinvar id is 1260503.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.524 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRHL2 | NM_024915.4 | c.*41G>A | 3_prime_UTR_variant | 16/16 | ENST00000646743.1 | NP_079191.2 | ||
GRHL2 | NM_001330593.2 | c.*41G>A | 3_prime_UTR_variant | 16/16 | NP_001317522.1 | |||
GRHL2 | XM_011517306.4 | c.*41G>A | 3_prime_UTR_variant | 16/16 | XP_011515608.1 | |||
GRHL2 | XM_011517307.4 | c.1763+2226G>A | intron_variant | XP_011515609.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRHL2 | ENST00000646743.1 | c.*41G>A | 3_prime_UTR_variant | 16/16 | NM_024915.4 | ENSP00000495564 | P1 | |||
GRHL2 | ENST00000395927.1 | c.*41G>A | 3_prime_UTR_variant | 16/16 | 2 | ENSP00000379260 |
Frequencies
GnomAD3 genomes AF: 0.378 AC: 57413AN: 151816Hom.: 11153 Cov.: 31
GnomAD3 genomes
AF:
AC:
57413
AN:
151816
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.391 AC: 94688AN: 242274Hom.: 18994 AF XY: 0.393 AC XY: 51284AN XY: 130558
GnomAD3 exomes
AF:
AC:
94688
AN:
242274
Hom.:
AF XY:
AC XY:
51284
AN XY:
130558
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.362 AC: 364580AN: 1006252Hom.: 69449 Cov.: 14 AF XY: 0.368 AC XY: 191770AN XY: 520616
GnomAD4 exome
AF:
AC:
364580
AN:
1006252
Hom.:
Cov.:
14
AF XY:
AC XY:
191770
AN XY:
520616
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.378 AC: 57473AN: 151934Hom.: 11171 Cov.: 31 AF XY: 0.381 AC XY: 28274AN XY: 74246
GnomAD4 genome
AF:
AC:
57473
AN:
151934
Hom.:
Cov.:
31
AF XY:
AC XY:
28274
AN XY:
74246
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1794
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 24, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Corneal dystrophy, posterior polymorphous, 4 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Autosomal dominant nonsyndromic hearing loss 28 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at